Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity.

Abstract excerpt

Unwanted immune responses against protein therapeutics can reduce efficacy or lead to adverse reactions. T-cell responses are key in the development of such responses, and are directed against immunodominant regions within the protein sequence, often associated with binding to several allelic variants of HLA class II molecules (promiscuous binders). Herein, we report a novel computational strategy to predict...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computer Simulation
• Share to Epitope Mapping